Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Biomarkers and Clinical Characteristics Of Patients With and Without DVT In The Intensive Care Unit (ICU)

Suman L. Sood, MD, Cathy Stabler, R.N., Angela E. Hawley, MS, Kenneth E. Guire, M.S., Susan Blackburn, R.N., Molly Oberdoerster, B.A., Mariam Khan, Jose A. Diaz, MD, Thomas W. Wakefield, MD

Blood (2013) 122 (21): 1124.

https://doi.org/10.1182/blood.V122.21.1124.1124

Published: 2013

Journal Articles

Novel E-Selectin Antagonist GMI-1271 Decreases Venous Thrombosis without Increased Bleeding Potential in a Mouse Model

Daniel Durant Myers, Jr., DVM, MPH, Dorian L Culmer, DVM, Jose A. Diaz, MD, Angela E. Hawley, MS, Peter K. Henke, MD, Suman L. Sood, MD, Robert E Sigler, DVM, PhD, Andrea T Obi, MD, John T. Patton, PhD, Thomas W. Wakefield, MD, John L. Magnani, PhD

Blood (2012) 120 (21): 3422.

https://doi.org/10.1182/blood.V120.21.3422.3422

Published: 2012

Journal Articles

Pan-Selectin Antagonist, GMI-1070 Decreases Venous Thrombosis in a Mouse Model,

Daniel Durant Myers, Jr., DVM, MPH, Peter K. Henke, MD, Jose A. Diaz, MD, Shirley K. Wrobleski, BS, Angela E. Hawley, MS, Dallas Slack, BS, Thomas W. Wakefield, MD, John T. Patton, PhD, John L. Magnani

Blood (2011) 118 (21): 3273.

https://doi.org/10.1182/blood.V118.21.3273.3273

Published: 2011

Journal Articles

Predicting Response to Therapy for Graft-vs-Host Disease (GvHD) with a Rapid Immune Function Assay.

Elias J. Anaissie, MD, Jose A. Diaz, MD, Monica L. Grazziutti, MD, Marisa H. Miceli, MD, Michele Fox-Cottler, MD, Bart Barlogie, MD, Frits van Rhee, MD

Blood (2007) 110 (11): 5012.

https://doi.org/10.1182/blood.V110.11.5012.5012

Published: 2007

Journal Articles

Monitoring Immune Function in the Allogeneic Transplant Recipient: Predicting Graft vs Host Disease (GvHD) and Infection.

Elias J. Anaissie, MD, Jose A. Diaz, MD, Monica L. Grazziutti, MD, Marisa H. Miceli, MD, Michele Fox-Cottler, MD, Bart Barlogie, MD, Frits van Rhee, MD

Blood (2007) 110 (11): 1966.

https://doi.org/10.1182/blood.V110.11.1966.1966

Published: 2007

Journal Articles

Outcome of Invasive Aspergillosis (IA) in 30 Patients with Hematological Cancer (Hem-Ca): Immunity Is (Almost) Everything.

Marisa H. Miceli, MD, Monica L. Grazziutti, MD, Gail L. Woods, MD, Jose A. Diaz, MD, Somashekar G. Krishna, MD, Elias N. Kiwan, MD, Nayyar Syed, MD, Bart Barlogie, MD, PHD, Elias J. Anaissie, MD

Blood (2006) 108 (11): 5314.

https://doi.org/10.1182/blood.V108.11.5314.5314

Published: 2006

Journal Articles

18 F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET): An Important Tool in the Management of Infection in Patients with Hematological Cancer.

Elias J. Anaissie, MD, Marisa H. Miceli, MD, Steve D. Strout, Laurie Jones-Jackson, MD, Ronald C. Walker, MD, Gary Purnell, MD, Jose A. Diaz, MD, Fariba Saghafifar, MD, Klaus A. Hollmig, MD, Anasthasios Fassas, MD, Guido Tricot, MD, Bart Barlogie, MD

Blood (2004) 104 (11): 1160.

https://doi.org/10.1182/blood.V104.11.1160.1160

Published: 2004

NARROW

Biomarkers and Clinical Characteristics Of Patients With and Without DVT In The Intensive Care Unit (ICU)

Novel E-Selectin Antagonist GMI-1271 Decreases Venous Thrombosis without Increased Bleeding Potential in a Mouse Model

Pan-Selectin Antagonist, GMI-1070 Decreases Venous Thrombosis in a Mouse Model,

Predicting Response to Therapy for Graft-vs-Host Disease (GvHD) with a Rapid Immune Function Assay.

Monitoring Immune Function in the Allogeneic Transplant Recipient: Predicting Graft vs Host Disease (GvHD) and Infection.

Outcome of Invasive Aspergillosis (IA) in 30 Patients with Hematological Cancer (Hem-Ca): Immunity Is (Almost) Everything.

18 F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET): An Important Tool in the Management of Infection in Patients with Hematological Cancer.

Email alerts

ASH Publications

American Society of Hematology

Biomarkers and Clinical Characteristics Of Patients With and Without DVT In The Intensive Care Unit (ICU)

Novel E-Selectin Antagonist GMI-1271 Decreases Venous Thrombosis without Increased Bleeding Potential in a Mouse Model

Pan-Selectin Antagonist, GMI-1070 Decreases Venous Thrombosis in a Mouse Model,

Predicting Response to Therapy for Graft-vs-Host Disease (GvHD) with a Rapid Immune Function Assay.

Monitoring Immune Function in the Allogeneic Transplant Recipient: Predicting Graft vs Host Disease (GvHD) and Infection.

Outcome of Invasive Aspergillosis (IA) in 30 Patients with Hematological Cancer (Hem-Ca): Immunity Is (Almost) Everything.

18 F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET): An Important Tool in the Management of Infection in Patients with Hematological Cancer.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only